Verseon Corp (VSN):企業の財務・戦略的SWOT分析

◆英語タイトル:Verseon Corp (VSN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14951
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardiovascular conditions linked with blood clots and has completed preclinical studies. Verseon has developed plasma kallikrein inhibitors that treats diabetic macular edema(DME) and related eye disorders; and novel angiogenesis inhibitors for the treatment of solid tumors. Its drugs starve tumors and suppress their growth. The company operates through its laboratory located in San Jose, California, the US. Verseon is headquartered in Fremont, California, the US.

Verseon Corp Key Recent Developments

Jan 29,2019: Verseon announces Directorate change
Nov 06,2018: Verseon: Result of AGM and changes to the board
Oct 24,2018: Novel oral therapies could transform the standard-of-care for Diabetic Macular Edema (DME) and lead to preventative treatment
Sep 18,2018: Verseon unveils new blockchain technology
Sep 18,2018: Verseon Unveils New Transformative Blockchain Technology[TPS : Biospace]

This comprehensive SWOT profile of Verseon Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Verseon Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Verseon Corp – Key Information
Verseon Corp – Overview
Verseon Corp – Key Employees
Verseon Corp – Key Employee Biographies
Verseon Corp – Key Operational Heads
Verseon Corp – Major Products and Services
Verseon Corp – History
Verseon Corp – Company Statement
Verseon Corp – Locations And Subsidiaries
Verseon Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Verseon Corp – Business Description
Verseon Corp – Corporate Strategy
Verseon Corp – SWOT Analysis
SWOT Analysis – Overview
Verseon Corp – Strengths
Verseon Corp – Weaknesses
Verseon Corp – Opportunities
Verseon Corp – Threats
Verseon Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Verseon Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Verseon Corp, Key Information
Verseon Corp, Key Ratios
Verseon Corp, Share Data
Verseon Corp, Major Products and Services
Verseon Corp, History
Verseon Corp, Key Employees
Verseon Corp, Key Employee Biographies
Verseon Corp, Key Operational Heads
Verseon Corp, Other Locations
Verseon Corp, Subsidiaries
Verseon Corp, Key Manufacturing facilities
Verseon Corp, Key Competitors
Verseon Corp, SWOT Analysis
Verseon Corp, Ratios based on current share price
Verseon Corp, Annual Ratios
Verseon Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Verseon Corp, Performance Chart
Verseon Corp, Ratio Charts

★海外企業調査レポート[Verseon Corp (VSN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Safe Orthopaedics SA (SAFOR):企業の製品パイプライン分析2018
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Daepyung Co., Ltd.:戦略・SWOT・企業財務分析
    Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bio-Rad Laboratories, Inc.:戦略・SWOT・企業財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • STP&I Public Company Limited:企業の戦略・SWOT・財務情報
    STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kuwait Food Company (Americana) K.S.C.P. (FOOD):企業の財務・戦略的SWOT分析
    Kuwait Food Company (Americana) K.S.C.P. (FOOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Techpool Bio-Pharma Co Ltd (Techpool Bio-Pharma) is a biopharmaceutical company. The company manufactures urinary protein biopharmaceuticals in critical care conditions. The company’s products include ulinastatin for injection, urinary kallidinogenase for injection, urokinase for injection a …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Achaogen Inc (AKAO):製薬・医療:M&Aディール及び事業提携情報
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company offers plazomicin for the treatment of serious bacterial infections including urinary t …
  • Trinity Health:企業の戦略的SWOT分析
    Trinity Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Milestone Scientific Inc (MLSS):製品パイプライン分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • Arkema SA:企業の戦略・SWOT・財務分析
    Arkema SA - Strategy, SWOT and Corporate Finance Report Summary Arkema SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Dynasil Corporation of America (DYSL)-医療機器分野:企業M&A・提携分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company also offers optical detection and analysis technology and components. It provides products such as beamsplitters, diffraction gratings, infrar …
  • LafargeHolcim Ltd.:企業のM&A・事業提携・投資動向
    LafargeHolcim Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LafargeHolcim Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • gel-e Inc:製品パイプライン分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Kalpataru Power Transmission Ltd:企業の戦略・SWOT・財務情報
    Kalpataru Power Transmission Ltd - Strategy, SWOT and Corporate Finance Report Summary Kalpataru Power Transmission Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Harte Hanks Inc (HHS):企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Genzyme Corp-医療機器分野:企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆